| Rethinking the use of ‘vulnerable’ SC Munari, AN Wilson, NJ Blow, CSE Homer, JE Ward Australian and New Zealand journal of public health 45 (3), 197-199, 2021 | 60 | 2021 |
| The phases of hepatitis C elimination: achieving WHO elimination targets A Pedrana, S Munari, M Stoové, J Doyle, M Hellard The Lancet Gastroenterology & Hepatology 6 (1), 6-8, 2021 | 50 | 2021 |
| Thiopurines and their optimization during infliximab induction and maintenance: a retrospective study in Crohn's disease RP Luber, L Dawson, S Munari, VC Kariyawasam, C Martin, PR Gibson, ... Journal of Gastroenterology and Hepatology 36 (4), 990-998, 2021 | 13 | 2021 |
| Chlamydia prevention and management in Australia: reducing the burden of disease SC Munari, JL Goller, ME Hellard, JS Hocking The Medical Journal of Australia 217 (10), 499, 2022 | 6 | 2022 |
| Quarantine preparedness–the missing factor in COVID-19 behaviour change? Qualitative insights from Australia A Davis, S Munari, J Doyle, B Sutton, A Cheng, M Hellard, L Gibbs BMC public health 22 (1), 1806, 2022 | 6 | 2022 |
| Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta‐analysis SC Munari, MW Traeger, V Menon, NH Latham, L Manoharan, ... Liver International 43 (12), 2625-2644, 2023 | 5 | 2023 |
| Priority populations’ experiences of isolation, quarantine and distancing for COVID-19: protocol for a longitudinal cohort study (Optimise Study) A Pedrana, A Bowring, K Heath, AJ Thomas, A Wilkinson, ... BMJ open 14 (1), e076907, 2024 | 3 | 2024 |
| Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis L Manoharan, NH Latham, SC Munari, MW Traeger, V Menon, ... Hepatology Communications 7 (4), e0082, 2023 | 3 | 2023 |
| COVID‐19 disaster recovery capitals: A conceptual framework to guide holistic and strengths‐based support strategies P Quinn, S Munari, K Block, S Walker, J Liberman, J Wallace, D Horyniak, ... Health Promotion Journal of Australia 35 (2), 355-364, 2024 | 2 | 2024 |
| Facilitators and barriers to adopting a multifaceted chlamydia management intervention in general practice: qualitative findings from Management of Chlamydia Cases in Australia … SC Munari, J Coombe, H Bittleston, M Temple-Smith, CK Fairley, ... Australian Journal of Primary Health 31 (1), 2025 | | 2025 |
| Young people’s preferences and motivations for STI partner notification: observational findings from the 2024 Sex, Drugs and Rock ‘n’Roll survey SC Munari, JL Goller, J Coombe, A Orozco, S Eddy, J Hocking, M Hellard, ... Sexual Health 22 (1), 2025 | | 2025 |
| Streamlining documentation in patient electronic medical records: An example of chlamydia consultation shortcuts JL Goller, H Bittleston, S Munari, K McNamee, D Bateson, L Sanci, ... Australian Journal of General Practice 53 (10), 777-781, 2024 | | 2024 |
| Chlamydia retesting remains low among young women in Australia: an observational study using sentinel surveillance data, 2018–2022 SC Munari, AL Wilkinson, J Asselin, L Owen, P Read, R Finlayson, ... Sexual Health 21 (2), 2024 | | 2024 |
| A multifaceted intervention to support chlamydia management in Australian general practice: qualitative study exploring resource implementation and adoption S Munari, J Coombe, H Bittleston, M Temple-Smith, C Fairley, D Bateson, ... SEXUAL HEALTH 21 (4), 16-17, 2024 | | 2024 |
| The Optimise Study: Vaccination knowledge, attitudes and beliefs F Saich, E Kwong, K Heath, A Altermatt, S Munari, B Merner, S Hill, ... Burnet Institute, 2021 | | 2021 |
| The Optimise Study: Impact of government restrictions on risk mitigation strategies F Saich, E Kwong, K Heath, A Altermatt, S Munari, B Merner, S Hill, ... Burnet Institute, 2021 | | 2021 |
| The Optimise Study: The impact of COVID-19 on income and finances F Saich, E Kwong, K Heath, A Altermatt, S Munari, B Merner, S Hill, ... Burnet Institute, 2021 | | 2021 |
| A Target 6-Thioguanine Nucleotide Level≥ 125 is Associated with a Higher Rate and Longer Durability of Response in Infliximab-Thiopurine Combination Therapy: A Retrospective … RP Luber, VC Kariyawasam, LP Dawson, SC Munari, PR Gibson, ... Gastroenterology 152 (5), S388, 2017 | | 2017 |
| P386 A target 6-thioguanine nucleotide≥ 125 is associated with a higher rate and longer durability of response in infliximab–thiopurine combination therapy: a retrospective … R Luber, V Kariyawasam, L Dawson, S Munari, P Gibson, M Sparrow, ... Journal of Crohn's and Colitis 11 (suppl_1), S273-S274, 2017 | | 2017 |
| Combination therapy with infliximab and a thiopurine vs. infliximab monotherapy in Crohn's disease RP Luber, VC Kariyawasam, LP Dawson, SC Munari, PR Sparrow, ... JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31, 141-142, 2016 | | 2016 |
